Document: Draft guidance on the conduct of clinical trials during public health emergencies-2026/3/4

Document: Records of data processing activity for the Union Product Database-2026/4/1

国家药监局关于医用透明质酸钠产品管理类别的公告（2022年第103号）-2022/11/14

国家药监局关于银黄含化滴丸和热炎宁合剂转换为非处方药的公告（2023年第75号）-2023/6/20

Draft Guidance: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act-2023/12/6

Document: Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests-2025/1/22

Document: List of medicinal products under additional monitoring-2025/2/24

Document: Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026-2025/4/1

Document: European Shortages Monitoring Platform (ESMP): National competent authority reporting templates-2025/5/13

Document: Outcome of written procedures finalised during the period from 4 March 2025 to 28 May 2025-2025/6/19